Pharmaceutical

MIRA Pharmaceuticals Reports Successful Formulation Results Supporting Development of MIRA-55 as a Non-Opioid Oral Therapy for Chronic Inflammatory Pain

Optimized Oral Formulation Demonstrates Favorable Oral Bioavailability Together with Robust Brain and Liver Distribution Following Oral Administration MIAMI, FL /...

Canada’s Drug Agency Issues Positive Reimbursement Recommendation for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN

This recommendation represents an important step towards improving access for Canadians living with rare kidney diseasesWALTHAM, Mass., July 09, 2026...

Medical Care Technologies Showcases Strength of Operating Subsidiaries with New Websites, Automated Systems, and Star-Powered Auction Momentum

Infinite Auctions and Real Game News Deliver Tangible Results and Non-Dilutive Funding for Core Technology Initiatives MESA, AZ / ACCESS...

error: Content is protected !!